Integrative Genomic and Single‐Cell Insights Into Efferocytosis‐Mediated Immune Regulation in Clear Cell Renal Cell Carcinoma
Mediators of Inflammation · 2025
DOI: 10.1155/mi/8710699 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mediators of Inflammation, 2025. Verfasst von Bing Shi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Nantong Hospital of Traditional Chinese Medicine, Nantong, 226001, China, ntzyy.com. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms, Genomics. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical and Health Research Project of Zhejiang Province.
Abstract (Originalsprache)
Background
Efferocytosis, the phagocytic clearance of apoptotic cells, plays a key role in tumor progression and immune regulation, but its prognostic significance and molecular mechanisms in clear cell renal cell carcinoma (ccRCC) remain unclear.
Methods
Four efferocytosis‐related pathways were curated, and the pathway activities were quantified in ccRCC. Prognostic genes were identified by univariate Cox regression and used to construct linear survival models with multiple algorithms, with the optimal model selected by cross‐validation. Associations between the risk score and tumor mutational burden (TMB), mutation profiles, and copy number variation (CNV) were subsequently evaluated. Multiomics integration highlighted RAC1 as a key risk gene, which was further examined using single‐cell and spatial transcriptomics (ST) to characterize expression patterns, tumor microenvironment interactions, and pathway enrichments. Protein‐level validation was performed using immunohistochemistry (IHC) data from the Human Protein Atlas.
Results
Efferocytosis pathway activity was upregulated in ccRCC, increased with disease stage, and correlated with poorer survival. The ridge regression‐based prognostic model demonstrated consistent predictive performance across independent datasets and was associated with higher TMB, specific mutation patterns, and increased CNV. Notably, RAC1, identified as the top weighted gene in the model, was overexpressed in association with copy number amplification, showing preferential enrichment in malignant core regions and strong links to oncogenic signaling.
Conclusion
Efferocytosis activation characterizes aggressive ccRCC. The developed prognostic model and identification of RAC1 as a central effector link efferocytosis‐related risk to immune remodeling and oncogenic signaling, providing potential biomarkers and therapeutic targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Nantong Hospital of Traditional Chinese Medicine, Nantong, 226001, China, ntzyy.com.
- Clinical Medical Research Center, Nantong Hospital of Traditional Chinese Medicine, Nantong, 226001, China, ntzyy.com.
- Henan Key Laboratory of Cancer Epigenetics, Cancer Institute, The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, 471003, China, haust.edu.cn.
- Department of Urology, Ningbo Municipal Hospital of Traditional Chinese Medicine (TCM), Affiliated Hospital of Zhejiang Chinese Medical University, Ningbo, Zhejiang, 315010, China, ningbo.gov.cn.
- Department of Urology, Affiliated Lianyungang Clinical College of Nantong University, The Second People's Hospital of Lianyungang, Lianyungang, China, lygey.com.
ORCID-Profile: Bing Shi, Chao Chen, Mingcong Zhang, Shuijie Shen
Förderung
- Medical and Health Research Project of Zhejiang Province
Zitieren
APA
Shi, B., Deng, M., Ma, J., Chen, C., Peng, A., Zhu, A., Yang, R., Jin, Z., Zhu, J., Zhang, M., & Shen, S. (2025). Integrative Genomic and Single‐Cell Insights Into Efferocytosis‐Mediated Immune Regulation in Clear Cell Renal Cell Carcinoma. Mediators of Inflammation. https://doi.org/10.1155/mi/8710699
Vancouver
Shi B, Deng M, Ma J, Chen C, Peng A, Zhu A, et al. Integrative Genomic and Single‐Cell Insights Into Efferocytosis‐Mediated Immune Regulation in Clear Cell Renal Cell Carcinoma. Mediators of Inflammation. 2025. doi:10.1155/mi/8710699
BibTeX
@article{Shi2025,
author = {Shi, Bing and Deng, Minghao and Ma, Jiakang and Chen, Chao and Peng, Aijin and Zhu, Anli and Yang, Rongchao and Jin, Zhenhua and Zhu, Jian and Zhang, Mingcong and Shen, Shuijie},
title = {Integrative Genomic and Single‐Cell Insights Into Efferocytosis‐Mediated Immune Regulation in Clear Cell Renal Cell Carcinoma},
journal = {Mediators of Inflammation},
year = {2025},
doi = {10.1155/mi/8710699}
}
EUVIMED